Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8259)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2014 (publication date) through Apr 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hummel R, Sie C, Watson DI, Wang T, Ansar A, Michael MZ, Hoek MVD, Haier J, Hussey DJ. MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines. World J Gastroenterol 2014; 20(40): 14904-14912 [PMID: 25356050 DOI: 10.3748/wjg.v20.i40.14904] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i40/14904.htm |
| Number | Citing Articles |
| 1 |
Cameron C. J. Lang, Megan Lloyd, Said Alyacoubi, Saqib Rahman, Oliver Pickering, Tim Underwood, Stella P. Breininger. The Use of miRNAs in Predicting Response to Neoadjuvant Therapy in Oesophageal Cancer. Cancers 2022; 14(5): 1171 doi: 10.3390/cancers14051171
|
| 2 |
Michelle J. Nyhan, Tracey R. O’Donovan, Antonius W. M. Boersma, Erik A. C. Wiemer, Sharon L. McKenna. MiR-193b promotes autophagy and non-apoptotic cell death in oesophageal cancer cells. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2123-6
|
| 3 |
Mohammadreza Bazavar, Jafar Fazli, Amir Valizadeh, Binfang Ma, Erfan Mohammadi, Zatollah Asemi, Forough Alemi, Masoomeh Maleki, Shilong Xing, Bahman Yousefi. miR-192 enhances sensitivity of methotrexate drug to MG-63 osteosarcoma cancer cells. Pathology - Research and Practice 2020; 216(11): 153176 doi: 10.1016/j.prp.2020.153176
|
| 4 |
Ning Wang, Chen Zhu, Ye Xu, Wenliang Qian, Min Zheng. Negative Regulation of PTEN by MicroRNA-221 and Its Association with Drug Resistance and Cellular Senescence in Lung Cancer Cells. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/7908950
|
| 5 |
Amrita Kundu, Joginder Singh, Jayanta Kumar Pal, Shubhra Sankar Ray. Predicting drug-resistant miRNAs in cancer. Network Modeling Analysis in Health Informatics and Bioinformatics 2022; 12(1) doi: 10.1007/s13721-022-00398-8
|
| 6 |
Wanli Yang, Jiaojiao Ma, Wei Zhou, Xin Zhou, Bo Cao, Hongwei Zhang, Qingchuan Zhao, Daiming Fan, Liu Hong. Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer. Expert Review of Gastroenterology & Hepatology 2017; 11(12): 1151 doi: 10.1080/17474124.2017.1372189
|
| 7 |
Wenzhi Liu, Mengkao Li, Xiangming Chen, Shan Zhu, Hailong Shi, Dawei Zhang, Cheng Cheng, Baosheng Li. MicroRNA-1 suppresses proliferation, migration and invasion by targeting Notch2 in esophageal squamous cell carcinoma. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-23421-3
|
| 8 |
Ying-ying Jin, Qing-juan Chen, Kun Xu, Hong-tao Ren, Xing Bao, Yi-nan Ma, Yang Wei, Hong bing Ma. Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN. Molecular and Cellular Biochemistry 2016; 422(1-2): 161 doi: 10.1007/s11010-016-2816-9
|
| 9 |
Chen Zi, Dexin Zeng, Jiyong Zhou, Jianjun Dai, Luyan Jiang, Feng Xue, Yuan Jiang, Baoguang Li. Selected microRNA-192 mutant indicates association with several function genes in bovine cells. Genes & Genomics 2018; 40(4): 361 doi: 10.1007/s13258-017-0635-3
|
| 10 |
Amy Buckley, Becky Bibby, Margaret Dunne, Susan Kennedy, Maria Davern, Breandán Kennedy, Stephen Maher, Jacintha O’Sullivan. Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells. Pharmaceuticals 2019; 12(1): 33 doi: 10.3390/ph12010033
|
| 11 |
Christina Just, Juliana Knief, Pamela Lazar-Karsten, Ekaterina Petrova, Richard Hummel, Christoph Röcken, Ulrich Wellner, Christoph Thorns. MicroRNAs as Potential Biomarkers for Chemoresistance in Adenocarcinomas of the Esophagogastric Junction. Journal of Oncology 2019; 2019: 1 doi: 10.1155/2019/4903152
|
| 12 |
Tomasz Kolenda, Kacper Guglas, Magda Kopczyńska, Joanna Sobocińska, Anna Teresiak, Renata Bliźniak, Katarzyna Lamperska. Good or not good: Role of miR-18a in cancer biology. Reports of Practical Oncology & Radiotherapy 2020; 25(5): 808 doi: 10.1016/j.rpor.2020.07.006
|
| 13 |
Jan Roška, João Lobo, Danica Ivovič, Lenka Wachsmannová, Thomas Mueller, Rui Henrique, Carmen Jerónimo, Miroslav Chovanec, Dana Jurkovičová. Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours. International Journal of Molecular Sciences 2023; 24(3): 2495 doi: 10.3390/ijms24032495
|
| 14 |
Hong Yu, Jianying Sun, Shaochang Jiang, Ying Xu. MicroRNA‑490‑3p regulates cell proliferation and apoptosis in gastric cancer via direct targeting of AKT1. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.7042
|
| 15 |
Christine Kestens, Peter D Siersema, Jantine WPM van Baal. Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer. World Journal of Gastroenterology 2016; 22(1): 1-7 doi: 10.3748/wjg.v22.i1.1
|
| 16 |
Naixin Ding, Xiujin Sun, Tingting Wang, Lei Huang, Jing Wen, Yiqin Zhou. miR‑378a‑3p exerts tumor suppressive function on the tumorigenesis of esophageal squamous cell carcinoma by targeting Rab10. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3639
|
| 17 |
Bernhard Biersack. Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs. Non-coding RNA Research 2017; 2(1): 1 doi: 10.1016/j.ncrna.2016.10.001
|
| 18 |
Bin Song, Xiangchen Liu, Huiling Dong, Rupak Roy. miR-140-3P Induces Chemotherapy Resistance in Esophageal Carcinoma by Targeting the NFYA-MDR1 Axis. Applied Biochemistry and Biotechnology 2023; 195(2): 973 doi: 10.1007/s12010-022-04139-5
|
| 19 |
Weiguo Zhang, Caipeng Lei, Junli Fan, Jing Wang. miR-18a promotes cell proliferation of esophageal squamous cell carcinoma cells by increasing cylin D1 via regulating PTEN-PI3K-AKT-mTOR signaling axis. Biochemical and Biophysical Research Communications 2016; 477(1): 144 doi: 10.1016/j.bbrc.2016.06.034
|
| 20 |
Song Yang, Peng Wang, Songhua Wang, Aihua Cong, Qi Zhang, Wenhao Shen, Xiangyi Li, Wei Zhang, Gaohua Han. <p>miRNA-181a-5p Enhances the Sensitivity of Cells to Cisplatin in Esophageal Adenocarcinoma by Targeting CBLB</p>. Cancer Management and Research 2020; : 4981 doi: 10.2147/CMAR.S251264
|
| 21 |
Jie Ma, Yanli Lin, Min Zhan, Dean L Mann, Sanford A Stass, Feng Jiang. Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer. Laboratory Investigation 2015; 95(10): 1197 doi: 10.1038/labinvest.2015.88
|
| 22 |
Yury O. Nunez Lopez, Berta Victoria, Pawel Golusinski, Wojciech Golusinski, Michal M. Masternak. Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes. Reports of Practical Oncology & Radiotherapy 2018; 23(1): 6 doi: 10.1016/j.rpor.2017.10.003
|
| 23 |
Chia-Wei Lin, Ming-Shiou Jan, Jung-Hua Steven Kuo. The microRNA expression profiles in extracellular vesicles from HeLa cancer cells in response to cationic lipid- or polyethylenimine-mediated gene delivery. Journal of Drug Targeting 2019; 27(1): 94 doi: 10.1080/1061186X.2018.1491977
|
| 24 |
Xiaomeng Sun, Jiani Chen, Xintao Chen, Qianmin Gao, Wei Chen, Xun Zou, Feng Zhang, Shouhong Gao, Shi Qiu, Xiaoqiang Yue, Houshan Yao, Xuan Liu, Mingming Li, Zhijie Xu. A Systematic Review of Clinical Validated and Potential miRNA Markers Related to the Efficacy of Fluoropyrimidine Drugs. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/1360954
|
| 25 |
Zhi Yang, Rui Ma, Jie Li, Lina Zhao. Noncoding RNAs in esophageal cancer: A glimpse into implications for therapy resistance. Pharmacological Research 2023; 188: 106678 doi: 10.1016/j.phrs.2023.106678
|
| 26 |
Cheng-Han Lin, Chen-Hsun Tsai, Ching-Tung Yeh, Jui-Lin Liang, Wan-Chun Hung, Forn-Chia Lin, Wei-Lun Chang, Hao-Yi Li, Yun-Chin Yao, Tai-I Hsu, Yu-Cheng Lee, Yi-Ching Wang, Bor-Shyang Sheu, Wu-Wei Lai, Marcus J. Calkins, Michael Hsiao, Pei-Jung Lu. MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma. Oncotarget 2016; 7(26): 39680 doi: 10.18632/oncotarget.9444
|
| 27 |
Chi Zhang, Qunfeng Ma, Yinan Shi, Xue Li, Ming Wang, Junfeng Wang, Jianlin Ge, Zhinan Chen, Ziling Wang, Hong Jiang. A novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cell line Eca-109/5-FU with significant drug resistance-related characteristics. Oncology Reports 2017; 37(5): 2942 doi: 10.3892/or.2017.5539
|
| 28 |
Christiane Matuszcak, Kirsten Lindner, Ann-Kathrin Eichelmann, Damian J. Hussey, Jörg Haier, Richard Hummel. microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma. Surgical Oncology 2018; 27(3): 392 doi: 10.1016/j.suronc.2018.04.001
|
| 29 |
Preethi Krishnan, Sunita Ghosh, Bo Wang, Dongping Li, Ashok Narasimhan, Richard Berendt, Kathryn Graham, John R. Mackey, Olga Kovalchuk, Sambasivarao Damaraju. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer. BMC Genomics 2015; 16(1) doi: 10.1186/s12864-015-1899-0
|
| 30 |
Lili Li, Rongrong Xie, Qichun Wei. Network analysis of miRNA targeting m6A-related genes in patients with esophageal cancer. PeerJ 2021; 9: e11893 doi: 10.7717/peerj.11893
|
| 31 |
Amir Mokhlesi, Zahra Sharifi, Ahmad Berimipour, Sara Taleahmad, Mahmood Talkhabi. Identification of hub genes and microRNAs with prognostic values in esophageal cancer by integrated analysis. Non-coding RNA Research 2023; 8(3): 459 doi: 10.1016/j.ncrna.2023.05.009
|
| 32 |
David Vrana, Viktor Hlavac, Veronika Brynychova, Radka Vaclavikova, Cestmir Neoral, Jiri Vrba, Rene Aujesky, Marcel Matzenauer, Bohuslav Melichar, Pavel Soucek. ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer. International Journal of Molecular Sciences 2018; 19(3): 868 doi: 10.3390/ijms19030868
|
| 33 |
Yuelan Qin, Renba Liang, Pingan Lu, Lin Lai, Xiaodong Zhu. Depicting the Implication of miR-378a in Cancers. Technology in Cancer Research & Treatment 2022; 21: 153303382211343 doi: 10.1177/15330338221134385
|
| 34 |
Fu-jia Ren, Yao Yao, Xiao-yu Cai, Guo-ying Fang. Emerging Role of MiR-192-5p in Human Diseases. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.614068
|
| 35 |
Andrea Ritter, Marc Hirschfeld, Kai Berner, Gerta R�cker, Markus J�ger, Daniela Weiss, Markus Medl, Claudia N�thling, Sandra Gassner, Jasmin Asberger, Thalia Erbes. Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4920
|
| 36 |
Yan Wang, Yue Zhao, Andreas Herbst, Thomas Kalinski, Jiwei Qin, Xiaoyan Wang, Zhenzhong Jiang, Frank Benedix, Sabine Franke, Thomas Wartman, Peter Camaj, Walter Halangk, Frank T. Kolligs, Karl W. Jauch, Peter J. Nelson, Christiane J. Bruns. miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression. Annals of Surgery 2016; 264(5): 804 doi: 10.1097/SLA.0000000000001928
|
| 37 |
Tomoyuki Okumura, Hirohumi Kojima, Takeshi Miwa, Shinichi Sekine, Isaya Hashimoto, Shozo Hojo, Takuya Nagata, Yutaka Shimada. The expression of microRNA 574-3p as a predictor of postoperative outcome in patients with esophageal squamous cell carcinoma. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-0985-3
|
| 38 |
Ye Sol Kim, Sae Jeong Park, Yeon Seon Lee, Hyun Kyung Kong, Jong Hoon Park. miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer. Oncotarget 2106; 7(27): 42261 doi: 10.18632/oncotarget.9950
|
| 39 |
Wen-Tao Wang, Chang-Qing Guo, Guang-Hui Cui, Song Zhao. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma. World Journal of Gastroenterology 2019; 25(37): 5604-5618 doi: 10.3748/wjg.v25.i37.5604
|
| 40 |
Tirta Wardana, Siti Nur Chasanah, Risky Oktriani, Cita Herawati, Sumadi Lukman Anwar, Indwiani Astuti, Sofia Mubarika Haryana. Circulation microRNA expression profiles in patients with complete responses to chemoradiotherapy in nasopharyngeal carcinoma. Non-coding RNA Research 2022; 7(4): 233 doi: 10.1016/j.ncrna.2022.09.005
|
| 41 |
Li Li, Haifeng Zhang, Xiaolong Wang, Jiali Wang, Haitao Wei. Long non-coding RNA CASC2 enhanced cisplatin-induced viability inhibition of non-small cell lung cancer cells by regulating the PTEN/PI3K/Akt pathway through down-regulation of miR-18a and miR-21. RSC Advances 2018; 8(29): 15923 doi: 10.1039/C8RA00549D
|
| 42 |
Masato Hayashi, Hirofumi Kawakubo, Kazumasa Fukuda, Shuhei Mayanagi, Rieko Nakamura, Koichi Suda, Testu Hayashida, Norihito Wada, Yuko Kitagawa. THUMP domain containing 2 protein possibly induces resistance to cisplatin and 5‐fluorouracil in in vitro human esophageal squamous cell carcinoma cells as revealed by transposon activation mutagenesis. The Journal of Gene Medicine 2019; 21(12) doi: 10.1002/jgm.3135
|
| 43 |
Soudeh Ghafouri‐Fard, Hamed Shoorei, Sepideh Dashti, Wojciech Branicki, Mohammad Taheri. Expression profile of lncRNAs and miRNAs in esophageal cancer: Implications in diagnosis, prognosis, and therapeutic response. Journal of Cellular Physiology 2020; 235(12): 9269 doi: 10.1002/jcp.29825
|
| 44 |
Tomasz Kolenda, Anna Teresiak, Marta Kapałczyńska, Weronika Przybyła, Maria Zajączkowska, Renata Bliźniak, Katarzyna Lamperska. let-7d i miR-18a jako biomarkery w nowotworach głowy i szyi. Zeszyty Naukowe WCO, Letters in Oncology Science 2015; 12(3): 37 doi: 10.1016/j.onko.2015.08.001
|
| 45 |
Rhea Sullivan, Austin Montgomery, Anna Scipioni, Pooja Jhaveri, Adam T. Schmidt, Steven D. Hicks. Confounding Factors Impacting microRNA Expression in Human Saliva: Methodological and Biological Considerations. Genes 2022; 13(10): 1874 doi: 10.3390/genes13101874
|
| 46 |
Kai Wu, Yamei Hu, Kanglu Yan, Yu Qi, Chunyang Zhang, Dengyan Zhu, Donglei Liu, Song Zhao. microRNA‐10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPARγ in esophageal cancer. Journal of Cellular Physiology 2020; 235(2): 1247 doi: 10.1002/jcp.29040
|
| 47 |
A. K. Eichelmann, C. Matuszcak, K. Lindner, J. Haier, D. J. Hussey, R. Hummel. Complex role of miR-130a-3p and miR-148a-3p balance on drug resistance and tumor biology in esophageal squamous cell carcinoma. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-35799-1
|
| 48 |
Jayanta Kumar Pal, Shubhra Sankar Ray, Sankar K. Pal. Identifying Drug Resistant miRNAs Using Entropy Based Ranking. IEEE/ACM Transactions on Computational Biology and Bioinformatics 2021; 18(3): 973 doi: 10.1109/TCBB.2019.2933205
|
| 49 |
Patrick Sven Plum, Ute Warnecke-Eberz, Uta Drebber, Seung-Hun Chon, Hakan Alakus, Arnulf Heinrich Hölscher, Alexander Quaas, Christiane Josephine Bruns, Ines Gockel, Dietmar Lorenz, Ralf Metzger, Elfriede Bollschweiler. Upregulation of miR-17-92 cluster is associated with progression and lymph node metastasis in oesophageal adenocarcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-48624-0
|
| 50 |
Changlin Zhou, Lin Zhang, Peng Xu. Growth inhibition and chemo‑radiosensitization of esophageal squamous cell carcinoma by survivin‑shRNA lentivirus transfection. Oncology Letters 2018; doi: 10.3892/ol.2018.9280
|
| 51 |
Min Kang, Yan Li, Shengtao Zhu, Shutian Zhang, Shuilong Guo, Peng Li. MicroRNA‑193b acts as a tumor suppressor gene in human esophageal squamous cell carcinoma via target regulation of KRAS. Oncology Letters 2019; doi: 10.3892/ol.2019.10039
|
| 52 |
Tian-Liang Zheng, De-Ping Li, Zhan-Feng He, Song Zhao. miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0943-6
|
| 53 |
Kirsten Lindner, Ann-Kathrin Eichelmann, Christiane Matuszcak, Damian Hussey, Jörg Haier, Richard Hummel. Complex Epigenetic Regulation of Chemotherapy Resistance and Biology in Esophageal Squamous Cell Carcinoma via MicroRNAs. International Journal of Molecular Sciences 2018; 19(2): 499 doi: 10.3390/ijms19020499
|
| 54 |
Yun Zhang, Katherine M. Weh, Bridget A. Tripp, Jennifer L. Clarke, Connor L. Howard, Shruthi Sunilkumar, Amy B. Howell, Laura A. Kresty. Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model. Pharmaceuticals 2023; 16(12): 1697 doi: 10.3390/ph16121697
|
| 55 |
Baerxiaguli Zabihula, Mukedaisi Yiliyasi, Yanrong Lu, Adili Salai. MicroRNA‑490‑3p inhibits proliferation and stimulates apoptosis of ESCC cells via MAPK1 downregulation. Oncology Letters 2019; doi: 10.3892/ol.2019.10636
|
| 56 |
Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Nikta Rabiei, Reza Fathazam, Negin Rabiei, Haleh Piroozmand, Massoud Vosough, Neda Rahimian, Michael R. Hamblin, Hamed Mirzaei. The role of non-coding RNAs in chemotherapy for gastrointestinal cancers. Molecular Therapy - Nucleic Acids 2021; 26: 892 doi: 10.1016/j.omtn.2021.10.004
|
| 57 |
Ling Wei, Jujie Sun, Nasha Zhang, Yue Shen, Teng Wang, Zengjun Li, Ming Yang. Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.764313
|
| 58 |
Matheus Lohan-Codeço, Maria Luísa Barambo-Wagner, Luiz Eurico Nasciutti, Luis Felipe Ribeiro Pinto, Nathalia Meireles Da Costa, Antonio Palumbo. Molecular mechanisms associated with chemoresistance in esophageal cancer. Cellular and Molecular Life Sciences 2022; 79(2) doi: 10.1007/s00018-022-04131-6
|
| 59 |
Cailin Zhu, Weiyun Bi, Hongtao Li, Wen Wang. CircLONP2 Accelerates Esophageal Squamous Cell Carcinoma Progression via Direct MiR-27b-3p-ZEB1 Axis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.822839
|